πŸ›οΈ Verified NIH Record β€’ Updated 2023-10-02

TARGET BP I Clinical Trial (NCT02910414)

A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine Systemβ„’ Kit, in Subjects With Hypertension

πŸ”΅ Active, Not Recruiting Phase3 πŸ’Š Investigational Drug / Biologic Sponsor: Ablative Solutions, Inc.

🩺 Plain-English Summary (8th-Grade Level)

The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure controlled trial, comparing renal denervation performed with the Peregrine System Kit in the treatment group to the sham control group (without renal denervation - no alcohol infusion). Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central randomization.

Who can join: Review the eligibility criteria below.

Location: Cardiology PC β€” Birmingham, Alabama

Age range: 18 Years to 80 Years

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (5 Sites)

  • Cardiology PC β€” Birmingham, Alabama
  • Piedmont Heart Institute β€” Atlanta, Georgia
  • NC Heart and Vascular Research β€” Raleigh, North Carolina
  • Wake Forest University Baptist Medical Center β€” Winston-Salem, North Carolina
  • UT Southwestern Medical Center β€” Dallas, Texas

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Hypertension clinical trials

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—